Embera NeuroTherapeutics' Convertible Note - IV Round

Embera NeuroTherapeutics raised a round of funding on November 09, 2016. Investors include Keiretsu Capital.

Embera NeuroTherapeutics is a development-stage pharmaceutical company focused on treating a broad range of addictions where the major clinical challenge is a limited range of effective therapies. Emb…

Articles about Embera NeuroTherapeutics' Convertible Note - IV Round: